Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis
about
Atherosclerosis in psoriatic disease: latest evidence and clinical implicationsUnresolved questions in rheumatology: motion for debate: the data support evidence-based management recommendations for cardiovascular disease in rheumatoid arthritisThe Obesity Epidemic and Consequences for Rheumatoid Arthritis CareAn overview of psoriatic arthritis - epidemiology, clinical features, pathophysiology and novel treatment targetsMAP4K4 and IL-6+ Th17 cells play important roles in non-obese type 2 diabetes.Association between use of disease-modifying antirheumatic drugs and diabetes in patients with ankylosing spondylitis, rheumatoid arthritis, or psoriasis/psoriatic arthritis: a nationwide, population-based cohort study of 84,989 patientsAbnormal Glucose Metabolism in Rheumatoid ArthritisRisk of rheumatoid arthritis in patients with type 2 diabetes: a nationwide population-based case-control study.Sugar-sweetened soda consumption and risk of developing rheumatoid arthritis in women.Association of psoriasis with stroke and myocardial infarction: meta-analysis of cohort studies.Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritis: a UK population-based cohort study.Independent impact of gout on the risk of diabetes mellitus among women and men: a population-based, BMI-matched cohort study.Prevalence and Predictors of Pre-Diabetes and Diabetes among Adults 18 Years or Older in Florida: A Multinomial Logistic Modeling Approach.Cardiovascular risk in patients with psoriatic arthritis.Subsequent Type 2 Diabetes in Patients with Autoimmune DiseaseThe Epidemiology of Psoriatic Arthritis.Hydroxychloroquine improves insulin sensitivity in obese non-diabetic individualsAnti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistanceTraditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis.White blood cells count and incidence of type 2 diabetes in young men.The Effect of Sustained Inflammation on Hepatic Mevalonate Pathway Results in Hyperglycemia.Improving cardiovascular health and metabolic comorbidities in patients with psoriatic arthritisPsoriatic arthritis and diabetes: a population-based cross-sectional studyPsoriasis and new-onset diabetes: a Danish nationwide cohort studyManagement of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion.Psoriasis and risk of type 2 diabetes among women and men in the United States: a population-based cohort study.Risk of Incident Diabetes Mellitus Associated With the Dosage and Duration of Oral Glucocorticoid Therapy in Patients With Rheumatoid ArthritisDifferential white cell count and incident type 2 diabetes: the Insulin Resistance Atherosclerosis Study.Mitigation of disease- and treatment-related risks in patients with psoriatic arthritis.Management of psoriasis and psoriatic arthritis in a combined dermatology and rheumatology clinic.Cardiovascular risk in juvenile idiopathic arthritis.Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: a systematic review and meta-analysis.Safety of low- to medium-dose glucocorticoid treatment in rheumatoid arthritis: myths and reality over the years.Prevalence of comorbidities in Mexican mestizo patients with rheumatoid arthritis.Dipeptidyl Peptidase (DPP)-4 Inhibitor-Induced Arthritis/Arthralgia: A Review of Clinical Cases.Pathogenic Role of IL-17-Producing Immune Cells in Obesity, and Related Inflammatory Diseases.Tofacitinib for the treatment of moderate to severe chronic plaque psoriasis in Japanese patients: Subgroup analyses from a randomized, placebo-controlled phase 3 trial.Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation:Risk of diabetes mellitus among patients with myasthenia gravis.Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: a population-based cohort study.
P2860
Q26783501-CFF07075-9070-4D6B-8D30-823B127894E1Q26822912-4073EBEE-CC25-4A3A-803B-887DD3DD3D7FQ28074864-454F5CB3-0928-46BB-BBD1-778AA30FBD9EQ28077367-E203A9D5-584D-4828-BFF9-EF7BD2175F73Q30239799-AED0E9F8-8466-4A4B-A00C-E949B13FC8C6Q33650548-1633488E-54E2-4EBC-A297-445087E2E3D0Q33654451-6CBC5086-DD85-4135-96F0-B45290AB2A7BQ33838440-75E5EE5D-9066-491C-8F66-57847BEA7DD5Q34056227-14BAE8E2-AA5C-4405-9434-E1D5E20522B2Q34381490-BFC357A0-6241-45D3-8CFC-AF9AAE6A8E29Q35031069-875D0CD8-786A-48BF-B8D0-2A5FCEDC4E26Q35306091-ECB539F6-F2B1-468A-9F77-88C34F47970FQ35880642-FF663C40-641E-40CF-AFEF-3091D6D4B530Q35974962-3B69B26E-F907-4E94-9F68-C0455882B5FEQ36039522-64A83808-FF4D-4236-B233-8B1822CABBAEQ36175115-A966E638-74D5-4EA3-B129-421CDEE0B302Q36246086-F41C1077-5E2D-4297-91AB-F2D94086C1A7Q36246116-73F7D795-2351-4924-8088-6E1BC939CD56Q36464352-22A6E3E0-A8BF-4C82-85DC-678148939AC3Q36560432-158B7B7C-694C-4134-A60C-577A2FADB355Q36782818-C009A1AA-3700-445B-9C5A-7F8F4A6A3036Q36843650-74B785A7-6F0B-4AED-8D86-D9CF233A4B16Q36988417-E48BE213-4185-4E73-A477-AE5CAF7930E7Q37022693-9DE1E05F-A190-4F15-922A-54890EAF5B45Q37058791-4C5DAE20-DF7D-4412-832F-353A1D18F33EQ37095225-8FE81BF1-70DB-4BFF-9FA4-ADF187BE9F63Q37169479-13065FAA-3B72-4837-9553-C969E356F3FDQ37672638-6B58D3C8-45A8-4203-8B85-52277BA60396Q37713522-A96BC491-1A27-4CD4-8225-BCDC5E6F4EAAQ37929647-BF025D33-B4B6-4759-A1CC-85F2F5F74F6FQ38090373-E163E95D-F39A-4A74-88A7-081CA29DE6E3Q38114903-DD78354A-4019-4C56-9C1A-DFB7ED8DBB4BQ38210726-06C4274B-B5BD-4CD9-962E-040096031A58Q38691780-DF3D0EB8-20D9-4E88-B27A-0DBF4308E93BQ38731788-5C90D0D6-4B38-4055-9ED1-933355672DF2Q39434888-0E5A49AE-C4EE-404B-AADC-568573C1EB63Q40132474-F090C971-CABD-4257-86F2-FDBDA26EC88AQ40815110-3FD7D9FB-546F-444D-BFA1-5B5403FBBFB8Q41512959-70B921AC-2B33-4B81-903C-9038475E8B96Q41918910-316F151E-4418-406D-8F5E-6D2DF85D741F
P2860
Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Risk of diabetes among patient ...... riatic arthritis and psoriasis
@ast
Risk of diabetes among patient ...... riatic arthritis and psoriasis
@en
Risk of diabetes among patient ...... riatic arthritis and psoriasis
@nl
type
label
Risk of diabetes among patient ...... riatic arthritis and psoriasis
@ast
Risk of diabetes among patient ...... riatic arthritis and psoriasis
@en
Risk of diabetes among patient ...... riatic arthritis and psoriasis
@nl
prefLabel
Risk of diabetes among patient ...... riatic arthritis and psoriasis
@ast
Risk of diabetes among patient ...... riatic arthritis and psoriasis
@en
Risk of diabetes among patient ...... riatic arthritis and psoriasis
@nl
P2093
P2860
P356
P1476
Risk of diabetes among patient ...... riatic arthritis and psoriasis
@en
P2093
Claire Canning
Daniel H Solomon
Sebastian Schneeweiss
P2860
P304
P356
10.1136/ARD.2009.125476
P407
P50
P577
2010-06-28T00:00:00Z